A. Mark Fendrick

Q: What Schools Are Affiliated With A. Mark Fendrick

A. Mark Fendrick is affiliated with the following schools: Boston University, University of Michigan

A. Mark Fendrick's AcademicInfluence.com Rankings

A. Mark Fendrick

Philosophy

#7486

World Rank

#10707

Historical Rank

Logic

#4530

World Rank

#5839

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is A. Mark Fendrick Influential?

(Suggest an Edit or Addition)

(See a Problem?)

A. Mark Fendrick's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An evidence-based appraisal of reflux disease management — the Genval Workshop Report (1998) (935)
Willingness to Pay for a Quality-adjusted Life Year (2000) (902)
The economic burden of non-influenza-related viral respiratory tract infection in the United States. (2003) (738)
What is the price of life and why doesn't it increase at the rate of inflation? (2003) (582)
National estimates of the quantity and cost of informal caregiving for the elderly with dementia (2001) (430)
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease (2001) (385)
The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. (2003) (372)
Suboptimal statin adherence and discontinuation in primary and secondary prevention populations (2004) (352)
Impact of decreasing copayments on medication adherence within a disease management environment. (2008) (332)
The Health Effects of Restricting Prescription Medication Use Because of Cost (2004) (325)
Public use of automated external defibrillators. (2003) (317)
Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis (2003) (265)
Value-based insurance design. (2007) (237)
Estimating the cost of informal caregiving for elderly patients with cancer. (2001) (217)
A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. (2001) (207)
Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease (1995) (204)
Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers (2013) (186)
Dizziness presentations in U.S. emergency departments, 1995-2004. (2008) (179)
A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness Analysis (1993) (165)
Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States (2004) (162)
Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. (2004) (156)
Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications (2008) (151)
Helicobacter pylori-related disease: guidelines for testing and treatment. (2000) (149)
The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. (2000) (146)
Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes (2005) (144)
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis (2001) (143)
Extent and cost of informal caregiving for older Americans with symptoms of depression. (2004) (143)
Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care (2008) (140)
Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs (2003) (138)
Predicting Nursing Home Admission: Estimates From a 7-Year Follow-up of a Nationally Representative Sample of Older Americans (2004) (137)
Out-of-pocket health-care expenditures among older Americans with cancer. (2004) (135)
Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. (2003) (131)
Electron-beam computed tomography in the diagnosis of coronary artery disease: a meta-analysis. (2001) (128)
A national study of the quantity and cost of informal caregiving for the elderly with stroke (2002) (118)
Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? (2004) (118)
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. (1996) (112)
Comparing local and regional variation in health care spending. (2012) (111)
Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. (1996) (101)
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. (1999) (101)
Nystagmus assessments documented by emergency physicians in acute dizziness presentations: a target for decision support? (2011) (101)
Managed Care, Medical Technology, and Health Care Cost Growth: A Review of the Evidence (1998) (100)
Evidence that value-based insurance can be effective. (2010) (97)
Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. (1992) (95)
As tests evolve and costs of cancer care rise: reappraising stool‐based screening for colorectal neoplasia (2008) (89)
Informal caregiving for diabetes and diabetic complications among elderly americans. (2002) (85)
Stroke risk stratification in acute dizziness presentations (2015) (83)
Low-Cost, High-Volume Health Services Contribute The Most To Unnecessary Health Spending. (2017) (79)
Summing the risk of NSAID therapy (2007) (78)
Associations in breast and colon cancer screening behavior in women. (2005) (77)
Behavioral associations between prostate and colon cancer screening. (2005) (72)
Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. (2006) (72)
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. (2002) (69)
Is sepsis accurately coded on hospital bills? (2002) (69)
Use of BPPV Processes in Emergency Department Dizziness Presentations (2013) (68)
"We got mail": electronic communication between physicians and patients. (1999) (67)
Cost-effectiveness of automated external defibrillator deployment in selected public locations (2003) (66)
Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. (1996) (65)
Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. (2003) (65)
The costs of cancer to a major employer in the United States: a case-control analysis. (2000) (64)
Diagnosis and treatment of upper respiratory tract infections in the primary care setting. (2001) (60)
Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis (2002) (60)
A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis (2009) (60)
Informal caregiving for chronic lung disease among older Americans. (2002) (59)
Respiratory illness caused by picornavirus infection: a review of clinical outcomes (2001) (59)
Economic Evaluation of Vaccination Programmes (2002) (58)
The Impact of Out-of-Pocket Costs on the Use of Intrauterine Contraception Among Women With Employer-sponsored Insurance (2013) (58)
Quality Of Life Measurement Clarifies The Cost-Effectiveness Of Helicobacter Pylori Eradication In Peptic Ulcer Disease And Uninvestigated Dyspepsia (2001) (57)
Acute exacerbation of chronic bronchitis: a primary care consensus guideline. (2004) (57)
Primary-Care Physicians' Perceptions and Practices on the Management of GERD: Results of a National Survey (2005) (55)
Cost-utility of aspirin and proton pump inhibitors for primary prevention. (2011) (53)
Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs. (2006) (52)
Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs (2005) (51)
Applying value-based insurance design to low-value health services. (2010) (50)
Measuring Health-Related Quality of Life in Patients with Upper Gastrointestinal Disease (1998) (50)
Value of computed tomography scans in ED dizziness visits: analysis from a nationally representative sample. (2010) (49)
Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. (1998) (49)
The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists. (1999) (47)
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment (1996) (46)
Managed care and medical technology: implications for cost growth. (1997) (46)
Stroke risk after nonstroke emergency department dizziness presentations (2014) (45)
Approval times for new drugs: does the source of funding for FDA staff matter? (2003) (45)
OTC analgesics and drug interactions: clinical implications (2008) (44)
Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. (1996) (43)
Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis. (1999) (43)
Viral Respiratory Infections Due to Rhinoviruses: Current Knowledge, New Developments (2003) (42)
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience. (2003) (42)
Value-Based Insurance Design Improves Medication Adherence Without An Increase In Total Health Care Spending. (2018) (40)
Value-Based Insurance Design: A “Clinically Sensitive, Fiscally Responsible” Approach to Mitigate The Adverse Clinical Effects of High-Deductible Consumer-Directed Health Plans (2007) (39)
Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis. (2003) (38)
The Effect of a Large Regional Health Plan’s Value-based Insurance Design Program on Statin Use (2012) (38)
Out-of-Pocket Health Care Expenditures Among Older Americans with Dementia (2004) (38)
Health plan report cards: exploring differences in plan ratings. (1998) (37)
Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. (2001) (37)
A prescription for the Epley maneuver: www.youtube.com? (2012) (36)
Barriers to constraining health care cost growth. (2004) (35)
Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis. (2003) (35)
Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis. (2002) (35)
Hospital adoption of laparoscopic cholecystectomy. (1994) (34)
Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn. (2004) (34)
Cost-Effectiveness of the Screening and Treatment of Diabetic Retinopathy: What Are the Costs of Underutilization? (1992) (34)
The evidence base for the evaluation and management of dizziness. (2010) (33)
Asymptomatic gallstones revisited. Is there a role for laparoscopic cholecystectomy? (1993) (33)
Variation in medication adherence in heart failure. (2013) (33)
PPI use in the OTC era: who to treat, with what, and for how long? (2005) (33)
Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018 (2021) (33)
Waiting for Care: Queuing and Resource Allocation (1987) (32)
New and Dis-Improved: On the Evaluation and Use of Less Effective, Less Expensive Medical Interventions (2004) (32)
Cardiologists performing peripheral angioplasties: impact on utilization. (2001) (31)
Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States (2002) (31)
Medication Adherence and Heart Failure (2014) (31)
Economic analysis in dermatology. (2002) (30)
Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy (2001) (30)
Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease. (1999) (30)
Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. (2000) (29)
Improving cancer screening adherence: using the "teachable moment" as a delivery setting for educational interventions. (2004) (29)
Potential clinical and economic effects of homocyst(e)ine lowering. (2000) (29)
Value-based insurance design: embracing value over cost alone. (2009) (29)
Effects of Episode-Based Payment on Health Care Spending and Utilization: Evidence from Perinatal Care in Arkansas (2017) (29)
Cost‐effectiveness analysis: cardiovascular benefits of proton pump inhibitor co‐therapy in patients using aspirin for secondary prevention (2011) (29)
Cost-effectiveness of saline-assisted hysterosonography and office hysteroscopy in the evaluation of postmenopausal bleeding: a decision analysis. (2001) (28)
Value-based insurance design: aligning incentives, benefits, and evidence in oncology. (2012) (28)
Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies. (2001) (28)
Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? (2004) (28)
Global Budgets and Technology-Intensive Medical Services. (2013) (27)
Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death (2005) (27)
The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas (2000) (27)
Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects. (1997) (27)
Connecticut's Value-Based Insurance Plan Increased The Use Of Targeted Services And Medication Adherence. (2016) (27)
The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clinical trial. (2005) (27)
Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention. (2008) (26)
Fast food franchises in hospitals. (2002) (26)
Right-Sizing Prenatal Care to Meet Patients' Needs and Improve Maternity Care Value. (2020) (26)
Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis (2001) (26)
Cost-effectiveness comparison of therapy for psoriasis with a methotrexate-based regimen versus a rotation regimen of modified cyclosporine and methotrexate. (2002) (26)
The role of economic evaluation in infection control. (2001) (25)
Provider knowledge, attitudes, and treatment preferences for early pregnancy failure. (2010) (25)
Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. (2019) (25)
Value-based insurance design: more health at any price. (2012) (25)
Improved health benefits of increased use of thrombolytic therapy. (1994) (24)
Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension. (2003) (24)
Diagnostic testing for influenza: review of current status and implications of newer treatment options. (1999) (24)
Women's health and the Affordable Care Act: high hopes versus harsh realities? (2014) (24)
Defining cause of death in stroke patients: The Brain Attack Surveillance in Corpus Christi Project. (2006) (23)
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy (2002) (23)
Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? (2005) (23)
Changes in peptic ulcer and gastritis/duodenitis in Great Britain, 1970-1985. (1990) (23)
The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice. (2012) (23)
A controlled trial of value-based insurance design – The MHealthy: Focus on Diabetes (FOD) trial (2009) (22)
Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists (2001) (22)
Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies. (2003) (22)
Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection? (1999) (22)
A Clinician's Guide to the Selection of NSAID Therapy (2002) (21)
Price elasticity and medication use: cost sharing across multiple clinical conditions. (2014) (21)
Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers (2008) (21)
Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists (2006) (21)
Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015. (2020) (20)
Decomposing pharmaceutical cost growth in different types of health plans. (2001) (20)
Value based insurance design: maintaining a focus on health in an era of cost containment. (2009) (20)
Rising out-of-pocket costs in disease management programs. (2006) (20)
The spectrum of acute bronchitis (2001) (20)
Recognizing peptic ulcer disease. Keys to clinical and laboratory diagnosis. (1999) (19)
Pharmaceutical cost growth under capitation: a case study. (2000) (19)
PATIENT, PHYSICIAN, AND PAYER PERCEPTIONS AND MISPERCEPTIONS OF WILLINGNESS TO PAY FOR DIAGNOSTIC CERTAINTY (2000) (18)
NSAIDs without a prescription: over-the-counter access, under-counted risks (2002) (18)
Out-Of-Pocket Spending For Maternity Care Among Women With Employer-Based Insurance, 2008-15. (2020) (18)
The dynamics of innovation in minimally invasive therapy. (1993) (18)
Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia. (2004) (18)
Treatment of early pregnancy failure: does induced abortion training affect later practices? (2011) (18)
Automated External Defibrillator Deployment in High Schools andSenior Centers (2005) (17)
Value-based insurance design: benefits beyond cost and utilization. (2015) (17)
Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy. (2002) (17)
The impact of cost sharing on women's use of annual examinations and effective contraception (2018) (17)
The Tension Between Cost Containment and the Underutilization of Effective Health Services (1996) (17)
Coronary artery bypass grafting in octogenarians: clinical and economic outcomes at community-based healthcare facilities. (2002) (17)
Breast Screening Utilization and Cost Sharing Among Employed Insured Women After the Affordable Care Act. (2019) (17)
Primary care physician perceptions of non‐steroidal anti‐inflammatory drug and aspirin‐associated toxicity: results of a national survey (2006) (17)
Management of patients with symptomatic gastroesophageal reflux disease: a primary care perspective. (2001) (17)
Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia. (2006) (16)
A Survey Of Americans With High-Deductible Health Plans Identifies Opportunities To Enhance Consumer Behaviors. (2019) (15)
Improving Health Outcomes for Patients with Depression: A Population Health Imperative. Report on an Expert Panel Meeting. (2016) (15)
A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy--a comparison of sequential sigmoidoscopy and colonoscopy with immediate conversion from sigmoidoscopy to colonoscopy in patients with an abnormal screening sigmoidoscopy. (2000) (15)
Value and increased cost sharing in the American health care system. (2008) (15)
Cost of contraceptive methods to privately insured women in the United States. (2013) (15)
Primary care physicians perceptions and practices on the management of GERD: Results of a national survey (2003) (15)
Cost-effectiveness of colorectal cancer screening strategies. (1996) (15)
Adherence to Competing Colorectal Cancer Screening Strategies: 1065 (2005) (14)
Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model (2020) (14)
Precision Benefit Design-Using "Smarter" Deductibles to Better Engage Consumers and Mitigate Cost-Related Nonadherence. (2017) (14)
Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes Treatment (2019) (14)
Percutaneous stenting of incidental unilateral renal artery stenosis: decision analysis of costs and benefits. (2003) (14)
The impact of including passive benefits in cost-effectiveness analysis: the case of automated external defibrillators on commercial aircraft. (2003) (13)
Beyond usual care: the economic consequences of expanding treatment options in early pregnancy loss. (2015) (13)
Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia. (2002) (13)
Consumer Behaviors Among Individuals Enrolled in High-Deductible Health Plans in the United States (2017) (13)
Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. (2002) (13)
Accelerating Approval Times for New Drugs in the U.S (2004) (13)
COX-2 inhibitor use after Vioxx: careful balance or end of the rope? (2004) (13)
The role of economic evaluation in the diagnosis and treatment of Helicobacter pylori infection. (2000) (13)
Improving Benefit Design to Promote Effective, Efficient, and Affordable Care. (2016) (13)
Geographic Variation in Quality of Care for Commercially Insured Patients (2014) (13)
Innovation of novel antibiotics: an economic perspective. (2014) (12)
Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis. (1996) (12)
The effect of medical malpractice liability on rate of referrals received by specialist physicians (2013) (12)
Real-world impact of comparative effectiveness research findings on clinical practice. (2014) (12)
Differences in the reporting of care-related patient injuries to existing reporting systems. (2003) (12)
How to test for Helicobacter pylori in 2005. (2005) (12)
A pharmacoeconomic perspective on stroke prevention in atrial fibrillation. (2010) (11)
Crisis into opportunity: can COVID-19 help set a path to improved health care efficiency? (2020) (11)
IN2: THE ECONOMIC BURDEN OF VIRAL RESPIRATORY INFECTION IN THE UNITED STATES (2001) (11)
Emergency department documentation templates: variability in template selection and association with physical examination and test ordering in dizziness presentations (2011) (11)
Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. (2005) (11)
Trends in Patient Cost Sharing for Clinical Services Used as Quality Indicators (2010) (11)
Value-based insurance design in oncology. (2011) (11)
Availability and variation of publicly reported prescription drug prices. (2017) (10)
Treatment patterns for early pregnancy failure in Michigan. (2009) (10)
The Impact of Global Budgets on Pharmaceutical Spending and Utilization (2014) (10)
“The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Case of Katie Couric” (2003) (10)
"Fiscally responsible, clinically sensitive" cost sharing: contain costs while preserving quality. (2007) (10)
Coronary artery bypass grafting in Native Americans: a higher risk of death compared to other ethnic groups? (2001) (10)
Impact of Initial Triage Decisions on Nursing Intensity for Patients With Acute Chest Pain (1990) (10)
Outcomes research in Helicobacter pylori infection (1997) (10)
Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori“ Test and Treat” strategy for patients with suspected peptic ulcer disease? (2000) (10)
Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk (2021) (9)
Description and Validation of the Colorectal Cancer and Adenoma Incidence & Mortality (CRC-AIM) Microsimulation Model (2020) (9)
Practical advice on eradicating Helicobacter pylori infection. (1999) (9)
Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease. (1996) (8)
Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women. (2019) (8)
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population (2019) (8)
Value-Based Insurance Design: Aligning Incentives to Improve Cardiovascular Care (2015) (8)
Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia (2001) (8)
Out-of-Pocket Costs of Diagnostic Breast Imaging Services After Screening Mammography Among Commercially Insured Women From 2010 to 2017 (2021) (8)
Cost-effective use of NSAIDs: issues pertinent to coxib use in managed care. (2002) (8)
Value-based insurance design: implications for gastroenterology. (2010) (8)
Gastroenterologists utilize the referral for EGD to enhance colon cancer screening more effectively than primary care physicians (2006) (8)
IDENTIFICATION OF PATIENTS WITH RESECTABLE PANCREATIC CANCER: AT WHAT STAGE ARE WE? (1998) (8)
Trends in Birth Rates After Elimination of Cost Sharing for Contraception by the Patient Protection and Affordable Care Act (2020) (8)
Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance. (2021) (8)
Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori “Test and Treat” strategy for patients with suspected peptic ulcer disease? (2000) (8)
The future of health economic modeling: have we gone too far or not far enough? (2006) (7)
Coronary artery bypass grafting in Native Americans (2001) (7)
Medicare Advantage: Issues, Insights, and Implications for the Future (2016) (7)
Willingness to pay for diagnostic certainty (1999) (7)
The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA (2022) (7)
Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment. (1998) (7)
Willingness to pay for diagnostic certainty: comparing patients, physicians, and managed care executives. (1999) (7)
Using clinically nuanced cost sharing to enhance consumer access to specialty medications. (2014) (7)
Value-based insurance design in cardiology: using "clinical nuance" to improve quality of care and contain costs. (2012) (7)
Gaps in Treatment, Treatment Resumption, and Cost Sharing (2012) (7)
Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019 (2021) (7)
Helicobacter pylori and NSAID gastropathy: An ambiguous association (2001) (7)
The effectiveness initiative. II: The spectrum of effectiveness research. (1995) (7)
Implantable or external defibrillators for individuals at increased risk of cardiac arrest: where cost-effectiveness hits fiscal reality. (2006) (7)
Effect of a Nurse-Led Psychoeducational Intervention on Healthcare Service Utilization Among Adults With Advanced Cancer. (2015) (7)
Percutaneous Stenting of Incidental Unilateral Renal Artery Stenosis: Decision Analysis of Costs and Benefits (2003) (6)
Electron beam computed tomography in the diagnosis of obstructive coronary artery disease. (2001) (6)
Developments in Influenza Prevention and Treatment (2000) (6)
Helicobacter pylori-more light, less heat (1998) (6)
The Price Will Be Right-How to Help Patients and Providers Benefit from the New CMS Transparency Rule. (2021) (6)
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population (2021) (6)
The Costs of Cancer: Cancer-related Conditions Can Add Dramatically to Overall Costs of Care (2002) (6)
Attitudes About Consumer Strategies Among Americans in High-deductible Health Plans (2019) (6)
Treatment of Symptomatic Cholelithiasis in France: A Decision Analysis Comparing Cholecystectomy and Biliary Lithotripsy (1992) (6)
How Would Low-Income Communities Prioritize Medicaid Spending? (2020) (6)
Breast Screening Utilization and Cost Sharing Among Employed Insured Women Following the Affordable Care Act: Impact of Race and Income. (2019) (6)
Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency. (2019) (6)
Incorporating Value-Based Care Into Oncology. (2020) (6)
Assessment of Self-monitoring of Blood Glucose in Individuals With Type 2 Diabetes Not Using Insulin (2019) (6)
Surprise Billing for Colonoscopy: The Scope of the Problem (2020) (6)
GASTROESOPHAGEAL REFLUX : THERAPY CONSIDERATIONS AFTER FAILURE OF LOW-DOSE, NONPRESCRIPTION H2RAS (1999) (5)
Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured (2021) (5)
Therapeutic options for GERD: what's the correct approach? (2000) (5)
GLUCAGON PRESCRIPTIONS FOR DIABETES PATIENTS AFTER EMERGENCY DEPARTMENT VISITS FOR HYPOGLYCEMIA. (2018) (5)
Utilization Impact of Cost-Sharing Elimination for Preventive Care Services: A Rapid Review (2021) (5)
Utilization and outcomes of office-based testing for Helicobacter pylori (HP) in symptomatic primary care patients (1998) (5)
A path to improve colorectal cancer screening outcomes: faculty roundtable evaluation of cost-effectiveness and utility. (2020) (5)
Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model (2020) (5)
Waste in the Medicare Program: a National Cross-Sectional Analysis of 2017 Low-Value Service Use and Spending (2020) (5)
Surgeon predictions on growth of minimal invasive therapy: the difficulty of estimating technologic diffusion. (2000) (5)
The effectiveness initiative. I. Medical practice guidelines. (1995) (5)
A commentary on the potential of Value-Based Insurance Design (VBID) to contain costs and preserve quality (2008) (5)
COMPARATIVE RESEARCH Direct Medical Care Costs of Unstable Angina Pectoris in a Defined Population (2015) (5)
Value added radiology: using existing radiology services to improve cancer screening. (2005) (5)
Cost-effectiveness of symptomatic gallstone management: what exactly are we measuring? (1992) (4)
Cost Analysis of Transthoracic Cardioversion of Atrial Fibrillation With and Without Ibutilide Pretreatment (2000) (4)
Impact of NSAID choice and patient symptoms on the cost-effectiveness of strategies to prevent NSAID gastropathy (1998) (4)
Value-based insurance coverage for bariatric surgery: time for surgeons to lead the change. (2019) (4)
188: Dizziness Presentations in U.S. Emergency Departments, 1995-2004: Doing More, Getting Less? (2008) (4)
Value-based insurance design: aligning incentives and evidence in pulmonary medicine. (2013) (4)
Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients. (2020) (4)
Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care. (2021) (4)
The Utilization and Costs of Grade D USPSTF Services in Medicare, 2007–2016 (2021) (4)
Regional Variation in Medication Adherence (2011) (4)
Inside out: reversing the focus on emergency departments to enhance efficiency. (2013) (4)
Cost-Sharing, Postpartum Contraceptive Use, and Short Interpregnancy Interval Rates Among Commercially Insured Women. (2020) (4)
Management of patients with known duodenal ulcer disease but unknown Helicobacter pylori status (1995) (4)
Understanding the Behavioral Response to Medical Innovation (1996) (4)
Allergen-Induced Inflammation and the Role of Immunoglobulin E (IgE) (2001) (3)
Novel multicancer early detection technology-potential value to employers and the workforce. (2020) (3)
Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population (2021) (3)
Naloxone fi ll rates after opioid overdose (2019) (3)
Mo1598 ESTIMATING THE IMPACT OF IMPERFECT ADHERENCE TO STOOL-BASED COLORECTAL CANCER SCREENING STRATEGIES ON COMPARATIVE EFFECTIVENESS USING THE CRC-AIM MICROSIMULATION MODEL (2020) (3)
Value Based Insurance Design: Restoring Health To The Health Care Cost Debate (2009) (3)
Homocyst(e)ine and Coronary Heart Disease (2012) (3)
Financial Burden of Advanced Imaging in Radiology (FAIR Study) (2022) (3)
Levers to reduce use of unnecessary services: creating needed headroom to enhance spending on evidence-based care. (2018) (3)
Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit. (2021) (3)
The Arkansas Payment Improvement Initiative: Early Perceptions of Multi-Payer Reform in a Fragmented Provider Landscape (2015) (3)
Out-Of-Pocket Payments for Part D Covered Medications by Medicare Fee-For-Service Beneficiaries with Heart Failure with Reduced Ejection Fraction. (2021) (3)
A Care Coordination Intervention Improves Symptoms but not Charges in High-Risk Patients with Inflammatory Bowel Disease. (2021) (3)
Patient reported outcomes in genital gender-affirming surgery: the time is now (2022) (3)
Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing (2022) (3)
Helicobacter pylori—More Light, Less Heat (1998) (3)
Cost-effectiveness of once in a lifetime screening unsedated endoscopy in 50 year-old white males with uncomplicated GERD (2001) (3)
A randomized, controlled trial to assess a novel colorectal cancer screening strategy: the conversion strategy (2000) (3)
What do primary care physicians think about Barrett's esophagus, the relationship between GERD & H. pylori, and treatment of nocturnal heartburn? (2003) (3)
Differences in physician compensation for cardiovascular services by age, sex, and race. (1997) (3)
Access to innovative treatment of erectile dysfunction: clinical, economic, and quality-of-life considerations. (2000) (3)
PHARMACY MANAGEMENT TRENDS: A GUIDE FOR NEW PHYSICIANS (2000) (3)
Delivery of acute unscheduled healthcare: who should judge whether a visit is appropriate (or not)? (2018) (3)
Value-based insurance design for diabetes mellitus: approaches to optimal pharmacoeconomic implementation. (2010) (3)
Expanding coverage for essential care during COVID-19. (2020) (3)
Impact of unsedated transnasal endoscopy (T-EGD) on the management of dyspepsia: A decision analysis (2001) (2)
Short-term risk of stroke after dizziness presentation. Reply. (2014) (2)
Expanding the "safe harbor" in high-deductible health plans: better coverage and lower healthcare costs. (2017) (2)
Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population (2022) (2)
Impact of an Episode-Based Payment Initiative by Commercial Payers in Arkansas on Procedure Volume: an Observational Study (2019) (2)
The challenges ahead for accountable care organizations (ACOs). (2011) (2)
Cost-effectiveness of step-up vs. Step-down therapy for symptomatic gerd: An international perspective (2000) (2)
Decision analytic modeling and NSAID gastropathy could we be more sensitive? (2000) (2)
Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population (2018) (2)
Understanding and improving value frameworks with real-world patient outcomes. (2018) (2)
Confronting hysteria: a reply to Fairman and Curtiss. (2008) (2)
Value-Based Insurance Design in the Medicare Prescription Drug Benefit: An Analysis of Policy Options (2009) (2)
Cost Sharing for Emergency Surgical Conditions-The Moral, Clinical, and Financial Hazards. (2021) (2)
Clinical and economic assessment of new surgical technologies. (1995) (2)
Endoscopic outcomes analysis. (2001) (2)
Is all "skin in the game" fair game? The problem with "non-preferred" generics. (2014) (2)
Refining the Recipe for Alternative Payment Models for Surgical Care-Importance of Patient Mix and Venue Match. (2021) (2)
Mechanisms to improve pharmaceutical use in managed care: to study controls, control the studies. (2003) (2)
The impact of over-the-counter histamine-2-antagonists: Great expectations unfulfilled (1998) (2)
Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes (2021) (2)
Enhance care continuity post COVID-19. (2021) (2)
Prevalence and Magnitude of Potential Surprise Bills for Childbirth (2021) (2)
Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending (2022) (2)
Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United States (2021) (1)
Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection (2022) (1)
Predicting effects of minimal invasive therapy. (1996) (1)
Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition (2022) (1)
Cost sharing and branded antidepressant initiation among patients treated with generics. (2018) (1)
Thrombolytic therapy: just do it. (1995) (1)
The impact of value-based insurance design on oncology drugs. (2016) (1)
EPR22-119: Cost-Effectiveness of Multi-Cancer Early Detection (MCED) Test in Subgroups With Smoking History or Obesity (2022) (1)
The role of physical therapy in occupational low back injuries. (2002) (1)
Thrombolytic therapy (1995) (1)
Impact of academic detailing and on-site serologic testing forH. pywrion management of suspected peptic ulcer disease by primary care providers (2000) (1)
Comparative effectiveness research and formulary placement: the case of diabetes. (2013) (1)
The Need to Expand Coverage and Enhance Access to Essential Services on a Predeductible Basis Following COVID-19. (2020) (1)
The economics of resistant pathogens and antibiotic innovation. (2014) (1)
Cost-Sharing and Productivity (2012) (1)
State-Level Variation In Low-Value Care For Commercially Insured And Medicare Advantage Populations. (2022) (1)
Measures of the Burden of Medical Expenses. (2018) (1)
Tu1822 HIGHER IMPACT ON CLINICAL OUTCOMES FROM DELAYS IN COLORECTAL CANCER SCREENING WITH THE FECAL IMMUNOCHEMICAL TEST VS MULTITARGET STOOL DNA: CRC-AIM MICROSIMULATION MODEL RESULTS (2020) (1)
HEALING AND PREVENTION OF NSAID-ASSOCIATED ULCER DISEASE: IS SEEING BELIEVING? (1998) (1)
Alignment of Consumer and Provider Incentives: As Easy as Peanut Butter and Jelly (2014) (1)
Precision Benefit Design: Using Clinical Benefit to Guide How Health Care Dollars Are Spent (2018) (1)
Economic immunity in the ICU: continued support or pull the plug? (1999) (1)
Randomized trial of H. pylori test-and-treat intervention for primary care patients with suspected peptic ulcer disease (2000) (1)
CT colonography: Friend or foe of practicing endoscopists. (2009) (1)
Peptic Ulcer Guideline Team (2005) (1)
The Role of Gastroprotection in Patients on NSAID Therapy (2006) (1)
Economic evaluation of alternative adjuvant chemotherapy modalities for colorectal carcinoma. (1996) (1)
Cardiovascular risk reduction in the workforce: Optimizing cholesterol management to reduce the burden of cardiovascular disease (2010) (1)
Why Not Africa? An Exploration of the Correlation Between International Sporting Events and Development (2013) (1)
POSB44 Drivers of Value-Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test (2022) (1)
Sa1658 MICROSIMULATION STUDY OF LIFE-YEARS GAINED FROM SCREENING VERSUS FOLLOW-UP COLONOSCOPY USING THE CRC-AIM MODEL (2020) (1)
Precision medicines need precision patient assistance programs. (2019) (1)
Expand predeductible coverage without increasing premiums or deductibles. (2020) (1)
HELICOBACTER PYLORI ERADICATION: KILL THE BUG AND SAVE THE PILL? (1998) (1)
Healthcare Utilization in Community-Acquired Pneumonia Episodes of Care: A Comparison Across the Continuum of Managed Care (2009) (1)
Timing and Timeliness in Medical Care Evaluation (1996) (1)
PCN7: FAMILY CAREGIVING COSTS FOR THE ELDERLY WITH CANCER: ESTIMATES FROM A REPRESENTATIVE SAMPLE OF THE UNITED STATES (2000) (1)
Meeting the challenge of colorectal cancer screening. (2005) (1)
The clinical and economic effects of silver alloy urinary catheters to prevent urinary tract infection (1999) (1)
Self-reported use and benefit of over-the-counter histamine-2-receptor anatagonists in the community (2003) (1)
The drug price iceberg: more than meets the eye. (2019) (1)
The Economics of Viagra Revisited: The Price Is Right (2021) (1)
The Changing Health Insurance Coverage Landscape in the United States. (2020) (1)
Putting value into practice. (2012) (0)
PMI15: COST ANALYSIS FOR END-OF-LIFE CARE (2001) (0)
Cost and Effectiveness of Hepatitis B Immunization (1993) (0)
Opportunity after crisis: enhancing value in the COVID-19 rebound. (2022) (0)
Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic (2022) (0)
Reply (2014) (0)
Cancer Patients Need Better Information, and Payers Should Demand They Receive It (2014) (0)
PAR2 THE IMPACT OF SPECIALTY CARE ON THE UTILIZATION OF NEW DRUGS: THE CASE OF COX-2 SELECTIVE INHIBITORS (2005) (0)
The Need For Outcomes Research In Evaluating The Benefit Of Health Care Technology (1994) (0)
Clinical and economic impact of population-based screening for hepatitis C: A decision analysis (2000) (0)
A Word From the New Editors (2002) (0)
H. pylori eradication for individuals on chronic NSAID therapy: Should we kill the bug if you need the drug? (2001) (0)
Women'sHealthandtheAffordableCareAct:HighHopes VersusHarshRealities? (2014) (0)
EE126 Cost-Effectiveness of Multi-Cancer Early Detection (MCED) Testing Using Mixture Cure Modeling (MCM) (2022) (0)
EE5 Assessment of Value Based Price (VBP) for a Multi-Cancer Early Detection (MCED) Test in a Medicare Population (2022) (0)
The Patient Referred for EGD: An Opportunity for CRC Screening (2005) (0)
Factors associated with employee participation in a value-based insurance design initiative (2013) (0)
Abstract W P293: Opportunities For Interventions In Stroke-Dizziness Presentations: A Prospective Single Center Surveillance Study (2015) (0)
COST-EFFECTIVENESS OF COLORECTAL CANCER SCREENING STRATEGIES. AUTHOR'S REPLY (1996) (0)
Estimating t he C ost o f I nformal C aregiving f or E lderly Patients W ith C ancer (2001) (0)
Benefit Design to Promote Effective, Efficient, and Affordable Care: A Vital Direction for Health and Health Care (2016) (0)
Book reviews (2007) (0)
Tailoring complex care to patients' needs: myths, realities, and best next steps. (2021) (0)
Su053 COST-EFFECTIVENESS OF STOOL-BASED COLORECTAL CANCER SCREENING USING REPORTED REAL-WORLD ADHERENCE RATES IN A MEDICARE POPULATION (2021) (0)
Insights on site-of-care cancer research: both quality and cost information are necessary to guide policy. (2018) (0)
Highlights of this Issue (2004) (0)
The Debate Over Drug Costs: Instead of “How Much” We Spend, Let’s Focus on What We Get in Terms of Health (2015) (0)
Taking aim at short-term, short-sighted cost minimization. (2014) (0)
TRANSLATING KNOWLEDGE INTO POLICY: THE CASE OF VALUE BASED INSURANCE DESIGN (2014) (0)
Eliminating Financial Barriers to Breast Cancer Screening-When Free Is Not Really Free. (2023) (0)
Developing dialogue in health care. (2011) (0)
Economic Evaluation of Vaccination ProgrammesStatement Focusing on Viral Hepatitis (2002) (0)
Proteinuria and oral gold treatment. (1985) (0)
Beta-blocker use in heart failure: Should we pick up the pace in patients with low heart rates? (2003) (0)
After 25 years, AJMC® looks to the future: a Q&A with Michael E. Chernew, PhD, and A. Mark Fendrick, MD. (2020) (0)
Slowing in Healthcare Costs: Hold the Celebration (2014) (0)
PCV87 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION (2010) (0)
Development of a brief reflux disease question-naire (2000) (0)
HSR23-100: The Potential Clinical Impact of a Multi-Cancer Early Detection Test for Individuals With Missing Cancer Stage Information (2023) (0)
Informed choices in anti-inflammatory drug therapy: why patient risk matters. (2004) (0)
Reallocating Cervical Cancer Preventive Service Spending from Low to High-Value Clinical Scenarios. (2023) (0)
Taking stock at 2 years--continuing the journey. (2004) (0)
Characteristics and health service utilization of women enrolled in health plans still requiring cost-sharing for intrauterine device placement in 2014 (2016) (0)
Letter to the editor (multiple letters) (2004) (0)
Cost-Effectiveness of mt-sDNA versus Mailed FIT Outreach for Medicare Advantage Enrollees using the CRC-AIM Microsimulation Model (2022) (0)
Influence of induced abortion training on attitudes and treatment patterns for early pregnancy failure (2009) (0)
Stopping the flood: reducing harmful cascades of care. (2021) (0)
“Clinically nuanced” Medicaid cost-sharing (2018) (0)
Accountable Care Organizations: Looking for Answers to an Overspending, Underachieving System (2013) (0)
Waiving cost sharing for screening colonoscopy; free, but not clear. (2012) (0)
Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance Plan. (2022) (0)
The Use of the Dix-Hallpike Test and the Canalith Repositioning Maneuver in Emergency Department Dizziness Presentations: A Population-Based Study (P02.250) (2012) (0)
Informal Caregiving for Diabetes and Diabetic Complications Among Elderly Americans (2001) (0)
Baffled by NAFLD: the horse might be out of the barn but should not take us for a ride. (2021) (0)
PAO22 REFILL ADHERENCE IN OSTEOPOROTIC WOMEN WITH PRIMARY AND SECONDARY FRACTURE PREVENTION (2002) (0)
Toward a national hepatitis B vaccination program. (1994) (0)
Need for outcomes research in evaluating the benefit of new health care technology (1994) (0)
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy (2023) (0)
Equity enhancing policies that increase access and affordability of cervical cancer screening in the United States: A Preventive Medicine Golden Jubilee Commentary. (2022) (0)
Impact Of Decreasing Copayments OnMedication AdherenceWithin A Disease Management Environment Value-based cost sharing can increase patients ’ adherence to important medications (2007) (0)
The Hidden Value of Upper Endoscopy: A “Teachable Moment” for Colorectal Cancer Screening (2005) (0)
Developing dialogue in healthcare. (2011) (0)
Coverage for the Entire Cervical Cancer Screening Process Without Cost-Sharing: Lessons From Colorectal Cancer Screening. (2022) (0)
S266 Lifetime Impact of the Change in Modality as a Result of Eliminating Cost-Sharing for Follow-Up Colonoscopy After a Positive Stool Test for Colorectal Cancer Screening (2022) (0)
Open doors to primary care should add a "screen" to reduce low-value care. (2019) (0)
Correspondence regarding "A benefit-based copay for prescription drugs" [1] (multiple letters) (2002) (0)
Physician utilizaton by consumers of OTC proton pump inhibitors (2003) (0)
P19 Utilization of Low-Value and High-Value Care and Its Association with Cognitive Impairment (2022) (0)
The Editors Respond Regarding the Shortcomings in Reported Research on Value-Based Insurance Design (2008) (0)
The use and effect of OTC omeprazole for frequent heartburn (2002) (0)
How Might Patients and Physicians Use Transparent Health Care Prices to Guide Decisions and Improve Health Care Affordability? (2022) (0)
PAO21 MISSED OPPORTUNITIES IN PHARMACEUTICAL TREATMENT OF OSTEOPOROSIS IN POST-FRACTURE WOMEN (2002) (0)
Letter--Assessing the Effectiveness of V-BID Implementations. (2019) (0)
PCV31 US BUDGET IMPACT OF INCREASING ASPIRIN USAGE FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE (2009) (0)
Setting Priorities for Medicaid: The Views of Minority and Underserved Communities (2017) (0)
In response [7] (2005) (0)
EM4: CAN UNIT COSTS BE COMPARED ACROSS WESTERN EUROPEAN COUNTRIES? (2011) (0)
Changes in use of low-value services during the COVID-19 pandemic. (2022) (0)
PRACTICE MANAGEMENT: OPPORTUNITIES AND CHALLENGES Value-Based Insurance Design: Implications for Gastroenterology (2010) (0)
Changing the Health Care Cost Discussion from "How Much" to "How Well" (2015) (0)
Prevention of colorectal cancer with cox-2 inhibitors is unlikely to be cost-effective (2003) (0)
A reappraisal of hepatitis B virus vaccination strategies using cost‐effectiveness analysis (1993) (0)
Evidence in Oncology Value-Based Insurance Design : Aligning Incentives , Benefits , and (2011) (0)
PRP10: VARIATIONS IN COVERAGE FOR EFFECTIVE SERVICES FOR ASTHMA: IMPACT OF NATIONAL GUIDELINES (2001) (0)
ES1 COST-UTILITY ANALYSES OF NEW MEDICAL TECHNOLOGIES: OFTEN COST-EFFECTIVE, SOMETIMES COST-INEFFECTIVE, DOMINANT, OR DOMINATED, BUT ALMOST NEVER ‘DECREMENTALLY’ COST-EFFECTIVE (2006) (0)
Su1773 MORE FECAL IMMUNOCHEMICAL TESTS ARE NEEDED TO MATCH THE CLINICAL BENEFIT OF EQUIVALENT NUMBERS OF MULTITARGET STOOL DNA TESTS: CRC-AIM MICROSIMULATION MODEL RESULTS (2020) (0)
Ease of ordering high- and low-value services in various electronic health records. (2019) (0)
Putting money into effective treatments. (2002) (0)
Evaluation of a Best Practice Advisory on Ordering Prothrombin Time, International Normalized Ratio, and Partial Thromboplastin Time Tests. (2022) (0)
Determining the Benefits of Gender-Affirming Surgery-A Call for Action. (2021) (0)
A Physician Survey of Clinical Practice (2016) (0)
Variation in Women’s out of Pocket Costs for Preventive Services: Implications for Evaluations of the Affordable Care Act (2017) (0)
High Deductibles are Associated with Severe Disease, Catastrophic Out-of-pocket Payments for Emergency Surgical Conditions. (2023) (0)
Shifting away from emergency department and office-based urgent care: no place like home? (2022) (0)
The provider culture vis-à-vis new technologies may have greater impact on cost growth than health plans' cost containment strategies. (2004) (0)
Early impact of the Affordable Care Act: changes in cost sharing and women's use of preventive services (2016) (0)
PCN280 IMPACT OF ALIGNED SCREENING INTERVAL ON SCREENING OUTCOMES USING THE CRC-AIM MICROSIMULATION MODEL (2020) (0)
Low-Cost , High-Volume Health Services Contribute The Most To Unnecessary Health Spending An analysis of data for 2014 about forty-four low-value health services in the Virginia All Payer Claims Database (2017) (0)
Ten Years of Choosing Wisely to Reduce Low-Value Care. (2022) (0)
HP1 SUB-OPTIMAL STATIN COMPLIANCE IN PRIMARY AND SECONDARY PREVENTION POPULATIONS: SHOULD WE TARGET PATIENTS WITH THE MOST TO GAIN? (2002) (0)
"Benefit Design in the Post-ACA Environment" (2014) (0)
PCN289 ESTIMATING THE IMPACT OF IMPERFECT ADHERENCE TO STOOL-BASED COLORECTAL CANCER SCREENING STRATEGIES ON COMPARATIVE EFFECTIVENESS USING THE CRC-AIM MICROSIMULATION MODEL (2020) (0)
CN4: THE IMPACT OF THE DIAGNOSIS OF CANCER ON OUT-OF-POCKET HEALTH-CARE EXPENDITURES MADE BY THE US ELDERLY (2001) (0)
Value-Based Insurance Design in Cardiology (2012) (0)
Refining intensive care management programs: can providing the neediest patients the right care in the right setting improve health and reduce expenditures? (2022) (0)
Celebrating our 20th anniversary. (2015) (0)
Treatment patterns for early pregnancy failure among Michigan Medicaid participants (2006) (0)
The Utilization and Costs of USPSTF Grade D Services in Medicare, 2007‐2016 (2020) (0)
A new chapter in health reform. (2016) (0)
MD1: COST-EFFECTIVENESS OF AIRLINE DEFIBRILLATORS: IS PEACE OF MIND MORE IMPORTANT THAN SAVING LIVES? (2001) (0)
Welcome to JVBHM 2 Aspirin Therapy Targets CVD Risk 3 Drive Participation , Increase Effectiveness 3 Q & A : (2008) (0)
Fr553 PATIENT PERCEPTIONS ON TRANSITION FROM CLINIC-BASED INFUSIONS TO HOME-BASED INFUSIONS FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: A QUALITATIVE QUALITY IMPROVEMENT STUDY (2021) (0)
Women’s ACA knowledge and attitudes: implications for reproductive health care access, utilization and equity (2014) (0)
C12. Management and patients with past documented duodenal ulcer but unknown Helicobacter pylori status (1996) (0)
Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension (2022) (0)
Outcomes research in evaluating the benefit of health care technology (1995) (0)
The program on outcomes research in technology. (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With A. Mark Fendrick?

A. Mark Fendrick is affiliated with the following schools:

A. Mark Fendrick's Academic­Influence.com Rankings

Why Is A. Mark Fendrick Influential?

A. Mark Fendrick's Published Works

Published Works

What Schools Are Affiliated With A. Mark Fendrick?

A. Mark Fendrick's AcademicInfluence.com Rankings